GlassScriptPhysician profile
Seth L Noland
NPI 1851626329
$4,194.42
in general payments reported to CMS, 2019-2025
22 companies · $388 in 2025
The $388 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,105 · 2020: $178 · 2021: $768 · 2022: $403 · 2023: $786 · 2024: $567 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,763.41 | 2019-2023 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Endologix LLC | $602.39 | 2021-2024 | Torus Stent Graft System, Endocross Device |
| Smith+Nephew, INC. | $538.51 | 2022-2025 | Grafix Pl, Collagenase Santyl, Stravix Pl |
| Lemaitre Vascular, INC. | $200.39 | 2019-2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome, Restoreflow |
| Bard Peripheral Vascular, INC. | $181.97 | 2020-2025 | Rotarexs 6 F X 135 Cm |
| Bolton Medical INC | $164.26 | 2024 | Treo Abdominal Stent-Graft System |
| Shockwave Medical, INC | $151.08 | 2022 | |
| Silk Road Medical, INC. | $151.00 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Davol INC. | $108.51 | 2021 | |
| Kerecis Limited | $75.09 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $47.42 | 2023-2025 | Cygnus Matrix, Puraply |
| Solventum Corporation | $36.24 | 2024 | Activ.A.C. |
| E.R. Squibb & Sons, L.L.C. | $27.34 | 2023-2025 | Camzyos, Eliquis |
| Cashflow Solutions, LLC | $24.28 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Boston Scientific Corporation | $21.40 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $17.88 | 2024 | Indigo System |
| Elutia, INC. | $15.22 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.99 | 2022 | |
| Allergan, INC. | $14.50 | 2020 | |
| Cook Medical LLC | $14.40 | 2019 | |
| Veryan Medical Incorporated | $12.47 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Noland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.